Prime Medicine, Inc. PRME
Institutional shares held
92.4 Million
1.32M
calls
931K
puts
Total value of holdings
$311M
$4.44M
calls
$3.14M
puts
Market Cap
$323M
95,730,200
Shares Out.
Institutional ownership
96.51%
# of Institutions
186
We take great care to ensure that the data presented and summarized in this overview for Prime Medicine, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PRME
View all-
Alphabet Inc. Mountain View, CA16.6MShares$55.8 Million5.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.22MShares$31.1 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.47MShares$21.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.48MShares$18.5 Million0.21% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$17.2 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.75MShares$16 Million0.11% of portfolio
-
Nikko Asset Management Americas, Inc.3.63MShares$12.2 Million0.22% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.25MShares$10.9 Million0.01% of portfolio
-
Casdin Capital, LLC New York, NY3.17MShares$10.7 Million2.39% of portfolio
-
Woodline Partners LP San Francisco, CA3MShares$10.1 Million0.09% of portfolio
Latest Institutional Activity in PRME
Top Purchases
Top Sells
About PRME
Insider Transactions at PRME
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2025
|
Gv 2021 Gp, L.L.C. |
BUY
Open market or private purchase
|
Indirect |
1,500,000
+31.5%
|
$4,500,000
$3.3 P/Share
|
|
Aug 01
2025
|
Robert Nelsen Director |
BUY
Open market or private purchase
|
Indirect |
3,030,300
+32.72%
|
$9,090,900
$3.3 P/Share
|
|
Aug 01
2025
|
Arch Venture Partners X, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,030,300
+32.72%
|
$9,090,900
$3.3 P/Share
|
|
Aug 01
2025
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,030,300
+32.72%
|
$9,090,900
$3.3 P/Share
|
|
Jun 30
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$42,000
$2.52 P/Share
|
|
Jun 23
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$42,000
$2.16 P/Share
|
|
Jun 16
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$21,000
$1.49 P/Share
|
|
Jun 11
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$21,000
$1.6 P/Share
|
|
May 21
2025
|
Ann L. Lee Chief Technical Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$100,000
$1.13 P/Share
|
|
May 21
2025
|
Allan Reine Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
125,000
+50.0%
|
$125,000
$1.18 P/Share
|
|
May 20
2025
|
Richard Brudnick Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$20,000
$1.19 P/Share
|
|
Oct 08
2024
|
Keith Michael Gottesdiener Director |
BUY
Bona fide gift
|
Indirect |
226,925
+24.96%
|
-
|
|
Oct 08
2024
|
Keith Michael Gottesdiener Director |
SELL
Bona fide gift
|
Indirect |
226,925
-81.87%
|
-
|
|
Jun 05
2024
|
Keith Michael Gottesdiener Director |
BUY
Bona fide gift
|
Indirect |
250,000
+47.42%
|
-
|
|
Jun 05
2024
|
Keith Michael Gottesdiener Director |
SELL
Bona fide gift
|
Direct |
250,000
-9.76%
|
-
|
|
Feb 15
2024
|
Robert Nelsen Director |
BUY
Open market or private purchase
|
Indirect |
3,200,000
+50.0%
|
$19,200,000
$6.25 P/Share
|
|
Feb 15
2024
|
Arch Venture Partners X, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,200,000
+50.0%
|
$19,200,000
$6.25 P/Share
|
|
Feb 15
2024
|
Arch Venture Partners Xii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,200,000
+50.0%
|
$19,200,000
$6.25 P/Share
|
|
Nov 11
2023
|
Keith Michael Gottesdiener Director |
SELL
Bona fide gift
|
Indirect |
5,000
-15.54%
|
-
|
|
Nov 11
2023
|
Keith Michael Gottesdiener Director |
SELL
Bona fide gift
|
Direct |
7,500
-0.29%
|
-
|
Last 12 Months Summary
Buy / Acquisition
10.9M
Shares
From
8
Insiders
| Open market or private purchase | 10.9M shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders